Beijing Tiantan Valuation
| 600161 Stock | 19.41 0.26 1.36% |
At this time, the firm appears to be fairly valued. Beijing Tiantan Biol shows a prevailing Real Value of USD20.18 per share. The current price of the firm is USD19.41. Our model approximates the value of Beijing Tiantan Biol from analyzing the firm fundamentals such as Current Valuation of 33.62 B, profit margin of 0.24 %, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy.
Price Book 3.6068 | Enterprise Value 33.6 B | Enterprise Value Ebitda 16.1193 | Price Sales 7.336 | Trailing PE 30.3281 |
Fairly Valued
Today
Please note that Beijing Tiantan's price fluctuation is very steady at this time. Calculation of the real value of Beijing Tiantan Biol is based on 3 months time horizon. Increasing Beijing Tiantan's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Beijing Tiantan is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Beijing Stock. However, Beijing Tiantan's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.41 | Real 20.18 | Hype 19.41 |
The real value of Beijing Stock, also known as its intrinsic value, is the underlying worth of Beijing Tiantan Biol Company, which is reflected in its stock price. It is based on Beijing Tiantan's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Beijing Tiantan's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Beijing Tiantan Biological helps investors to forecast how Beijing stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Beijing Tiantan more accurately as focusing exclusively on Beijing Tiantan's fundamentals will not take into account other important factors: Beijing Tiantan Cash |
|
Beijing Tiantan Total Value Analysis
Beijing Tiantan Biological is presently estimated to have takeover price of 33.62 B with market capitalization of 38.38 B, debt of 1.43 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Beijing Tiantan fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
33.62 B | 38.38 B | 1.43 B |
Beijing Tiantan Investor Information
About 54.0% of the company shares are owned by insiders or employees . The book value of Beijing Tiantan was presently reported as 5.38. The company last dividend was issued on the 20th of June 2024. Beijing Tiantan Biol had 1.2:1 split on the 20th of June 2024. Based on the analysis of Beijing Tiantan's profitability, liquidity, and operating efficiency, Beijing Tiantan Biological is performing exceptionally good at this time. It has a great odds to report excellent financial results in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 2.9 B | 2.8 B |
|
| |||||
| Operating Income | 2.1 B | 2 B |
|
|
Beijing Tiantan Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Beijing Tiantan has an asset utilization ratio of 36.51 percent. This suggests that the Company is making USD0.37 for each dollar of assets. An increasing asset utilization means that Beijing Tiantan Biological is more efficient with each dollar of assets it utilizes for everyday operations.Beijing Tiantan Ownership Allocation
Beijing Tiantan holds a total of 1.98 Billion outstanding shares. Beijing Tiantan Biological retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Beijing Tiantan Profitability Analysis
The company reported the revenue of 5.18 B. Net Income was 1.1 B with profit before overhead, payroll, taxes, and interest of 2.89 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Beijing Tiantan's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Beijing Tiantan and how it compares across the competition.
About Beijing Tiantan Valuation
The stock valuation mechanism determines Beijing Tiantan's current worth on a weekly basis. Our valuation model uses a comparative analysis of Beijing Tiantan. We calculate exposure to Beijing Tiantan's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Beijing Tiantan's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3 B | 1.7 B |
Beijing Tiantan Quarterly Retained Earnings |
|
Complementary Tools for Beijing Stock analysis
When running Beijing Tiantan's price analysis, check to measure Beijing Tiantan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beijing Tiantan is operating at the current time. Most of Beijing Tiantan's value examination focuses on studying past and present price action to predict the probability of Beijing Tiantan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beijing Tiantan's price. Additionally, you may evaluate how the addition of Beijing Tiantan to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |